Skip to main content
. 2016 Jan 23;7(7):8172–8183. doi: 10.18632/oncotarget.6995

Figure 4. Anti-angiogenic properties of the identified HIF-1 inhibitors.

Figure 4

(A) Fluorescence images of GFP-expressing aortic endothelial cells in the presence of various concentrations of mycophenolate mofetil. (B) Tube formation and viability of co-cultures of human aortic endothelial cells and human mesenchymal stem cells after a 3-day exposure of PI-103, trametinib, mycophenolate mofetil, and niclosamide under normoxic condition. Assay data are expressed as mean ± SD from three measurements.